Role of NRF2 in Protection Against Hyperoxic Lung Injury in Mice
Overview
Molecular Biology
Authors
Affiliations
NRF2 is a transcription factor important in the protection against carcinogenesis and oxidative stress through antioxidant response element (ARE)-mediated transcriptional activation of several phase 2 detoxifying and antioxidant enzymes. This study was designed to determine the role of NRF2 in the pathogenesis of hyperoxic lung injury by comparing pulmonary responses to 95-98% oxygen between mice with site-directed mutation of the gene for NRF2 (Nrf2-/-) and wild-type mice (Nrf2+/+). Pulmonary hyperpermeability, macrophage inflammation, and epithelial injury in Nrf2-/- mice were 7.6-fold, 47%, and 43% greater, respectively, compared with Nrf2+/+ mice after 72 h hyperoxia exposure. Hyperoxia markedly elevated the expression of NRF2 mRNA and DNA-binding activity of NRF2 in the lungs of Nrf2+/+ mice. mRNA expression for ARE- responsive lung antioxidant and phase 2 enzymes was evaluated in both genotypes of mice to identify potential downstream molecular mechanisms of NRF2 in hyperoxic lung responses. Hyperoxia-induced mRNA levels of NAD(P)H:quinone oxidoreductase 1 (NQO1), glutathione-S-transferase (GST)-Ya and -Yc subunits, UDP glycosyl transferase (UGT), glutathione peroxidase-2 (GPx2), and heme oxygenase-1 (HO-1) were significantly lower in Nrf2-/- mice compared with Nrf2+/+ mice. Consistent with differential mRNA expression, NQO1 and total GST activities were significantly lower in Nrf2-/- mice compared with Nrf2+/+ mice after hyperoxia. Results demonstrated that NRF2 has a significant protective role against pulmonary hyperoxic injury in mice, possibly through transcriptional activation of lung antioxidant defense enzymes.
Thirty years of NRF2: advances and therapeutic challenges.
Zhang D Nat Rev Drug Discov. 2025; .
PMID: 40038406 DOI: 10.1038/s41573-025-01145-0.
Role of NRF2 in Pathogenesis of Alzheimer's Disease.
Chu C, Uruno A, Katsuoka F, Yamamoto M Antioxidants (Basel). 2025; 13(12.
PMID: 39765857 PMC: 11727090. DOI: 10.3390/antiox13121529.
Revisiting reactive oxygen species production in hypoxia.
Alva R, Wiebe J, Stuart J Pflugers Arch. 2024; 476(9):1423-1444.
PMID: 38955833 DOI: 10.1007/s00424-024-02986-1.
Anti-Inflammatory Therapeutic Mechanisms of Isothiocyanates: Insights from Sulforaphane.
Habtemariam S Biomedicines. 2024; 12(6).
PMID: 38927376 PMC: 11200786. DOI: 10.3390/biomedicines12061169.
Endesfelder S, Schmitz T, Buhrer C Int J Mol Sci. 2024; 25(10).
PMID: 38791361 PMC: 11121655. DOI: 10.3390/ijms25105323.